NASDAQ: NLTX       Neoleukin Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
11.38   +0.27 (2.43%)  10.87 - 11.94  555,100


Avg Volume (4 weeks):608,958
4 Weeks Range:8.00 - 12.89
4 Weeks Price Volatility (%):
52 Weeks Range:2.53 - 13.43
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Nile Therapeutics, Inc. (Nile) is a development-stage biopharmaceutical company in the business of commercially developing products for the treatment of cardiovascular diseases. The Company's product CD-NP, a chimeric natriuretic peptide is in Phase II clinical studies for the treatment of heart failure. The Company is developing CD-NP for an initial indication of acute decompensated heart failure (ADHF). The Company is also developing CU-NP, a pre-clinical rationally designed natriuretic peptide that consists of amino acid chains identical to those produced by the human body, specifically the ring structure of C-type natriuretic peptide (CNP), and the N- and C-termini of Urodilatin (URO).

  Be the first to like this.


2884  5185  599  230 

Top 10 Active Counters
 NIO 4.79-0.38 
 FCEL 2.22-0.66 
 CHK 0.593-0.004 
 AVP 5.60-0.05 
 GE 11.37-0.29 
 EEM 45.43+0.37 
 NTRP 1.42-0.03 
 SPY 331.34+0.04 
 FXI 43.47+0.48 
 GNPX 1.89+0.74 
Partners & Brokers